Literature DB >> 10636073

The liver in hereditary hemorrhagic telangiectasia (Weber-Rendu-Osler disease).

C Weik1, L Greiner.   

Abstract

BACKGROUND: Hereditary hemorrhagic telangiectasia (HHT, Osler disease) is an inborn error in the structure of different vessels. This leads to vascular malformations in multiple organ systems. In the liver vascular abnormalities are associated with a marked fibrosis and/or cirrhosis. METHODS AND
RESULTS: We found hepatic manifestation of Osler disease in four women and one man (51-63 years old) presenting initially with slight disturbances of liver function. In three patients progressive liver insufficiency developed. The characteristic histologic and sonographic findings are described and discussed.
CONCLUSION: Ultrasonography with color and Doppler analysis is diagnostic, replacing more extensive procedures like angiography, computer tomography, or magnetic resonance tomography.

Entities:  

Mesh:

Year:  1999        PMID: 10636073     DOI: 10.1080/003655299750024779

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  3 in total

1.  Health-related quality of life in a rare disease: hereditary hemorrhagic telangiectasia (HHT) or Rendu-Osler-Weber disease.

Authors:  Giovanna Pasculli; Francesco Resta; Edoardo Guastamacchia; Leonardo Di Gennaro; Patrizia Suppressa; Carlo Sabbà
Journal:  Qual Life Res       Date:  2004-12       Impact factor: 4.147

2.  Potential role of modifier genes influencing transforming growth factor-beta1 levels in the development of vascular defects in endoglin heterozygous mice with hereditary hemorrhagic telangiectasia.

Authors:  A Bourdeau; M E Faughnan; M L McDonald; A D Paterson; I R Wanless; M Letarte
Journal:  Am J Pathol       Date:  2001-06       Impact factor: 4.307

3.  Liver transplantation for hereditary hemorrhagic telangiectasia: Report of the European liver transplant registry.

Authors:  Jan Lerut; Giuseppe Orlando; René Adam; Carlo Sabbà; Robert Pfitzmann; Jurgen Klempnauer; Jacques Belghiti; Jacques Pirenne; Thierry Thevenot; Christian Hillert; Colin M Brown; Dominique Gonze; Vincent Karam; Olivier Boillot
Journal:  Ann Surg       Date:  2006-12       Impact factor: 12.969

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.